Atrás
Rango del Día
$13.47
$13.69
Rango de 52 Semanas
$6.85
$16.47
Volumen
5,564,223
Promedio 50D / 200D
$14.22
/
$11.17
Cierre Anterior
$13.36
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.4 | 0.2 |
| P/B | 1.1 | 3.0 |
| ROE % | -21.1 | 3.6 |
| Net Margin % | -24.6 | 3.8 |
| Rev Growth 5Y % | -5.4 | 9.9 |
| D/E | 1.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$15.25
+13.0%
Low: $12.00
High: $18.00
P/E Futuro
5.51
EPS Futuro
$2.45
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
14.62B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$0.00
$0.00 – $0.00
|
14.97B | 0 |
| FY2028 |
$3.25
$1.49 – $5.02
|
15.15B | 2 |
| FY2027 |
$2.67
$2.36 – $2.77
|
14.89B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | $0.53 | $0.57 | +7.1% |
| 2025-11-06 | $0.62 | $0.67 | +7.9% |
| 2025-08-07 | $0.56 | $0.62 | +11.5% |
| 2025-05-08 | $0.49 | $0.50 | +1.6% |
| 2025-02-27 | $0.61 | $0.54 | -11.5% |
| 2024-11-07 | $0.68 | $0.75 | +10.8% |
| 2024-08-08 | $0.68 | $0.69 | +1.8% |
| 2024-05-09 | $0.67 | $0.67 | -0.4% |
Dividend History
5 yr streakYield
0.04%
Payout Ratio
-0.16%
Growth (3Y)
0.00%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 09, 2026 | Mar 18, 2026 | $0.12 | 3.38% |
| Nov 24, 2025 | Dec 15, 2025 | $0.12 | 4.54% |
| Aug 22, 2025 | Sep 15, 2025 | $0.12 | 4.51% |
| May 23, 2025 | Jun 16, 2025 | $0.12 | 5.79% |
| Mar 10, 2025 | Mar 18, 2025 | $0.12 | 5.05% |
| Nov 22, 2024 | Dec 13, 2024 | $0.12 | 3.59% |
| Aug 23, 2024 | Sep 13, 2024 | $0.12 | 4.08% |
| May 23, 2024 | Jun 14, 2024 | $0.12 | 4.56% |
| Mar 08, 2024 | Mar 18, 2024 | $0.12 | 3.92% |
| Nov 22, 2023 | Dec 15, 2023 | $0.12 | 5.12% |
| Aug 23, 2023 | Sep 15, 2023 | $0.12 | 4.36% |
| May 23, 2023 | Jun 16, 2023 | $0.12 | 5.19% |
| Mar 08, 2023 | Mar 17, 2023 | $0.12 | 4.55% |
| Nov 22, 2022 | Dec 16, 2022 | $0.12 | 4.34% |
| Aug 23, 2022 | Sep 16, 2022 | $0.12 | 4.63% |
| May 23, 2022 | Jun 16, 2022 | $0.12 | 3.96% |
| Feb 23, 2022 | Mar 16, 2022 | $0.12 | 3.14% |
| Nov 22, 2021 | Dec 16, 2021 | $0.11 | 2.52% |
| Aug 23, 2021 | Sep 16, 2021 | $0.11 | 1.49% |
| May 21, 2021 | Jun 16, 2021 | $0.11 | 0.72% |
Puntos Clave
Revenue declined -5.44% annually over 5 years
Generating 1.94B in free cash flow
Capital efficient — spends only 2.65% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-5.44%
Revenue (1Y)-2.98%
Earnings (1Y)N/A
FCF Growth (3Y)-8.72%
Calidad
Return on Equity
-21.08%
ROIC-6.79%
Net Margin-24.58%
Op. Margin-18.62%
Seguridad
Debt / Equity
1.00
Current Ratio1.30
Interest Coverage-5.65
Valoración
P/E Ratio
-4.42
Forward P/E5.51
P/B Ratio1.06
EV/EBITDAN/A
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.98% | Revenue Growth (3Y) | -3.72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -5.44% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.30B | Net Income (TTM) | -3.51B |
| ROE | -21.08% | ROA | -9.45% |
| Gross Margin | 35.06% | Operating Margin | -18.62% |
| Net Margin | -24.58% | Free Cash Flow (TTM) | 1.94B |
| ROIC | -6.79% | FCF Growth (3Y) | -8.72% |
| Safety | |||
| Debt / Equity | 1.00 | Current Ratio | 1.30 |
| Interest Coverage | -5.65 | ||
| Dividends | |||
| Dividend Yield | 0.04% | Payout Ratio | -0.16% |
| Dividend Growth (3Y) | 0.00% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 5 yrs | ||
| Valuation | |||
| P/E Ratio | -4.42 | Forward P/E | 5.51 |
| P/B Ratio | 1.06 | P/S Ratio | 1.09 |
| PEG Ratio | -0.01 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 9.52 |
| Forward P/S | 1.06 | Fwd Earnings Yield | 18.15% |
| FCF Yield | 12.46% | ||
| Market Cap | 15.55B | Enterprise Value | 28.90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.30B | 14.74B | 15.43B | 16.26B | 17.89B |
| Net Income | -3.51B | -634.20M | 54.70M | 2.08B | -1.27B |
| EPS (Diluted) | -3.00 | -0.53 | 0.05 | 1.71 | -1.05 |
| Gross Profit | 5.01B | 5.62B | 6.44B | 6.50B | 5.58B |
| Operating Income | -2.66B | 10.10M | 766.20M | 1.61B | -34.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 37.19B | 41.50B | 47.69B | 50.02B | 54.84B |
| Total Liabilities | 22.48B | 22.87B | 27.22B | 28.95B | 34.35B |
| Shareholders' Equity | 14.71B | 18.64B | 20.47B | 21.07B | 20.49B |
| Total Debt | 14.70B | 14.31B | 18.37B | 19.53B | 23.36B |
| Cash & Equivalents | 1.35B | 734.80M | 991.90M | 1.26B | 701.20M |
| Current Assets | 9.22B | 9.52B | 12.98B | 10.64B | 10.90B |
| Current Liabilities | 7.09B | 5.78B | 7.78B | 6.75B | 9.88B |